Evaluation of commercial Salmonella O polyvalent and Vi antisera.

AUTOR(ES)

Evins, G M

RESUMO

Salmonella somatic polyvalent antisera for groups A through E or A through I with or without Vi and Salmonella Vi antisera were purchased from four commercial producers and evaluated. Center for Disease Control (CDC) methods and specifications were used. The four polyvalent and two of the four Vi antisera did not meet CDC performance specifications. Suggestions are made for improving the laboratory usefulness of the reagents and the product labeling.

Documentos Relacionados

• Assessment of availability and efficacy of commercial Salmonella grouping antisera.
• Changes in serotypes of enterotoxigenic Escherichia coli in Dhaka over time: usefulness of polyvalent antisera.
• Insolubilized Salmonella lipopolysaccharides as efficient immunoadsorbents for the preparation of specific Salmonella antisera.
• Evaluation of commercial antisera for Shigella serogrouping.
• Quality of commercially produced Shigella serogrouping and serotyping antisera.